ACM
FATE icon

Aquilo Capital Management’s Fate Therapeutics FATE Stock Holding History

Aquilo Capital Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-72,273
Closed -$1.41M – 15
2019
Q4 		$1.41M Hold
72,273
– – 0.96% 11
2019
Q3 		$1.12M Sell
72,273
-529,823
-88% -$10.2M 1.27% 11
2019
Q2 		$12.2M Sell
602,096
-95,000
-14% -$1.71M 9.04% 7
2019
Q1 		$12.2M Hold
697,096
– – 9.82% 7
2018
Q4 		$8.94M Sell
697,096
-287,500
-29% -$4.01M 9.04% 6
2018
Q3 		$16M Buy
984,596
+404,367
+70% +$4.78M 12.02% 4
2018
Q2 		$6.58M Buy
+580,229
New +$6.39M 5.49% 6

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return